FI850130L - Nya 8 -asylaminoergoliner. - Google Patents

Nya 8 -asylaminoergoliner.

Info

Publication number
FI850130L
FI850130L FI850130A FI850130A FI850130L FI 850130 L FI850130 L FI 850130L FI 850130 A FI850130 A FI 850130A FI 850130 A FI850130 A FI 850130A FI 850130 L FI850130 L FI 850130L
Authority
FI
Finland
Prior art keywords
acylaminoergoliner
nya
Prior art date
Application number
FI850130A
Other languages
English (en)
Other versions
FI850130A0 (fi
FI82466B (fi
FI82466C (fi
Inventor
Walter Haefliger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI850130A0 publication Critical patent/FI850130A0/fi
Publication of FI850130L publication Critical patent/FI850130L/fi
Publication of FI82466B publication Critical patent/FI82466B/fi
Application granted granted Critical
Publication of FI82466C publication Critical patent/FI82466C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI850130A 1984-01-12 1985-01-11 Foerfarande foer framstaellning av nya 8 -acylaminoergoliner. FI82466C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3400853 1984-01-12
DE3400853 1984-01-12

Publications (4)

Publication Number Publication Date
FI850130A0 FI850130A0 (fi) 1985-01-11
FI850130L true FI850130L (fi) 1985-07-13
FI82466B FI82466B (fi) 1990-11-30
FI82466C FI82466C (fi) 1991-03-11

Family

ID=6224786

Family Applications (1)

Application Number Title Priority Date Filing Date
FI850130A FI82466C (fi) 1984-01-12 1985-01-11 Foerfarande foer framstaellning av nya 8 -acylaminoergoliner.

Country Status (28)

Country Link
US (2) US4950672A (fi)
JP (1) JPH0655739B2 (fi)
AT (1) AT391317B (fi)
AU (3) AU583489B2 (fi)
BE (1) BE901456A (fi)
CA (1) CA1245640A (fi)
CH (1) CH664568A5 (fi)
CY (1) CY1542A (fi)
DE (1) DE3500251C2 (fi)
DK (1) DK169891B1 (fi)
ES (1) ES8605514A1 (fi)
FI (1) FI82466C (fi)
FR (1) FR2560196B1 (fi)
GB (1) GB2152507B (fi)
GR (1) GR850065B (fi)
HK (1) HK48590A (fi)
HU (1) HU197569B (fi)
IE (1) IE58228B1 (fi)
IL (1) IL74043A (fi)
IT (1) IT1214648B (fi)
LU (1) LU85725A1 (fi)
NL (1) NL193541C (fi)
NZ (1) NZ210818A (fi)
PH (1) PH23286A (fi)
PT (1) PT79818B (fi)
SE (1) SE460420B (fi)
SG (1) SG32390G (fi)
ZA (1) ZA85276B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197569B (en) * 1984-01-12 1989-04-28 Sandoz Ag Process for producing 8alpha-acylaminoergoline derivatives and pharmaceuticals comprising such compounds
DE3587860D1 (de) * 1984-04-09 1994-07-28 Schering Ag 2-substituierte Ergolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
HUT45248A (en) * 1986-01-24 1988-06-28 Sandoz Ag Process for producing 8alpha-(acylamino)-ergoline derivatives and pharmaceuticals comprising such compounds
US4931447A (en) * 1987-06-15 1990-06-05 Eli Lilly And Company Cycloalkylamides of (8β)-1-alkyl-6-(substituted) ergolines
US4981859A (en) * 1987-06-15 1991-01-01 Cycloalkylamides of (8 beta )-1-alkyl-6-(substituted)ergolines
DE3820159A1 (de) * 1987-06-23 1989-01-05 Sandoz Ag 8(alpha)-acylaminoergolin, seine herstellung und dieses enthaltende arzneimittel
IT1219652B (it) * 1987-06-23 1990-05-24 Sandoz Ag 8-acilamminoergolina,la sua preparazione e il suo impiego come medicamneto
DK338789A (da) * 1988-07-15 1990-01-16 Schering Ag 2-substituerede ergolinylurinstofderivater og fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler samt mellemprodukter til fremstilling deraf
GB8824744D0 (en) * 1988-10-21 1988-11-30 Erba Carlo Spa Antiemesis ergoline derivatives
DE3915950A1 (de) * 1989-05-12 1990-11-15 Schering Ag 8(alpha)-acylamino-ergoline, ihre herstellung und verwendung als arzneimittel
CN107405346A (zh) 2015-01-20 2017-11-28 Xoc制药股份有限公司 异麦角灵化合物及其用途
JP6856532B2 (ja) 2015-01-20 2021-04-07 エックスオーシー ファーマシューティカルズ インコーポレイテッドＸｏｃ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ エルゴリン化合物およびその使用
BR112019025420A2 (pt) 2017-06-01 2020-06-16 Xoc Pharmaceuticals, Inc. Compostos policíclicos e usos destes

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3218323A (en) * 1965-11-16 Esters of i,g-dimethyl-b-ergolenyl carbamic acid
US2864822A (en) * 1956-10-22 1958-12-16 Lilly Co Eli 9-amino-7-methyl-belta10-ergolene and derivatives thereof
CH622519A5 (en) * 1974-07-05 1981-04-15 Hoechst Ag Process for the preparation of hydroxyalkylxanthines
US4348392A (en) * 1974-07-19 1982-09-07 Sandoz Ltd. 8α-Substituted ergoline-I derivatives
GB1517971A (en) * 1974-07-19 1978-07-19 Sandoz Ltd 8alpha-substituted ergoline i derivatives
US3922347A (en) * 1974-12-19 1975-11-25 Lilly Co Eli Method of inhibiting prolactin secretion with 8-acylaminoergolenes
CH615929A5 (en) * 1975-06-02 1980-02-29 Sandoz Ag Process for the preparation of novel ergoline compounds
DE2656344A1 (de) * 1975-12-23 1977-07-07 Sandoz Ag Ergolinderivate, ihre verwendung und herstellung
CH622518A5 (en) * 1976-12-14 1981-04-15 Sandoz Ag Process for the preparation of novel ergoline compounds
CH644606A5 (de) * 1980-09-23 1984-08-15 Sandoz Ag Verfahren zur isomerisierung von 9,10-dihydrolysergsaeurederivaten.
DE3151912A1 (de) * 1981-12-23 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
HU197569B (en) * 1984-01-12 1989-04-28 Sandoz Ag Process for producing 8alpha-acylaminoergoline derivatives and pharmaceuticals comprising such compounds
HU195810B (en) * 1984-12-24 1988-07-28 Sandoz Ag Process for preparing new 8alpha-acyl-amino-ergoline derivatives and pharmaceutical compositions containing such compounds
IT1219652B (it) * 1987-06-23 1990-05-24 Sandoz Ag 8-acilamminoergolina,la sua preparazione e il suo impiego come medicamneto

Also Published As

Publication number Publication date
JPS60174783A (ja) 1985-09-09
CA1245640A (en) 1988-11-29
US5077298A (en) 1991-12-31
PT79818B (en) 1987-01-07
JPH0655739B2 (ja) 1994-07-27
GB8500454D0 (en) 1985-02-13
DE3500251A1 (de) 1985-07-18
IL74043A (en) 1988-10-31
AT391317B (de) 1990-09-25
ES539511A0 (es) 1986-03-16
GB2152507A (en) 1985-08-07
CH664568A5 (de) 1988-03-15
DK169891B1 (da) 1995-03-27
IE850064L (en) 1985-07-12
SE8500107D0 (sv) 1985-01-10
PH23286A (en) 1989-06-30
ES8605514A1 (es) 1986-03-16
IE58228B1 (en) 1993-08-11
PT79818A (en) 1985-02-01
NL8500008A (nl) 1985-08-01
IT8547538A0 (it) 1985-01-11
GB2152507B (en) 1987-07-15
AU3760985A (en) 1985-07-18
NL193541B (nl) 1999-09-01
IT1214648B (it) 1990-01-18
SG32390G (en) 1990-08-03
LU85725A1 (fr) 1985-10-22
FI850130A0 (fi) 1985-01-11
US4950672A (en) 1990-08-21
IL74043A0 (en) 1985-04-30
NZ210818A (en) 1989-02-24
HK48590A (en) 1990-06-29
CY1542A (en) 1991-03-22
AU609539B2 (en) 1991-05-02
SE460420B (sv) 1989-10-09
AU583489B2 (en) 1989-05-04
ZA85276B (en) 1986-08-27
FR2560196A1 (fr) 1985-08-30
SE8500107L (sv) 1985-07-13
AU2506788A (en) 1989-03-02
HUT37148A (en) 1985-11-28
DE3500251C2 (de) 1995-01-26
AU618290B2 (en) 1991-12-19
DK12685D0 (da) 1985-01-10
FI82466B (fi) 1990-11-30
BE901456A (fr) 1985-07-08
NL193541C (nl) 2000-01-04
FR2560196B1 (fr) 1986-07-18
FI82466C (fi) 1991-03-11
HU197569B (en) 1989-04-28
GR850065B (fi) 1985-05-03
ATA5985A (de) 1990-03-15
DK12685A (da) 1985-07-13
AU2506688A (en) 1989-02-23

Similar Documents

Publication Publication Date Title
FI855118A0 (fi) Foerfarande foer framstaellning av nya peptid-aldehyder.
FI852515A0 (fi) Foerfarande foer framstaellning av nya gangliosidderivat.
FI80883B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensotiazol- och bensotiofenderivat.
FI864320A0 (fi) Nya foereningar.
FI861750A0 (fi) Nya foereningar.
FI864062A0 (fi) Nya acrylsyraamider.
FI862801A0 (fi) Nya kemiska foereningar.
FI854434A0 (fi) Nya 5-amino-4-hydroxivaleryl-derivat.
FI851837L (fi) Foerfarande foer framstaellning av nya kompositioner.
FI853336L (fi) Nya medelst heterocyklisk acylgrupp substituerade aminoetrar.
FI852694L (fi) Nya isoindolinyl-alkyl-piperaziner.
FI863179A0 (fi) Nya benzamider.
FI850130A0 (fi) Nya 8 -asylaminoergoliner.
FI863007A0 (fi) Nya kemiska foereningar.
FI853181L (fi) Nya 6-substituerade mitomycinderivat.
FI854298L (fi) Framstaellningsfoerfarande av nya tienopyridinderivat.
FI855158A0 (fi) Nya allylaminer.
FI854088L (fi) Foerfarande foer framstaellning av nya pyridinderivat.
FI864099L (fi) Nya , -diaryl-4-aryl-4-hydroxi-1 -piperidin-butanamid-n-oxider.
FI853535A0 (fi) Foerfarande foer framstaellning av nya bensazolderivat.
FI853415A0 (fi) Framstaellning foer nya diarylfoereningar.
FI853005A0 (fi) Nya aminoalkylpenem-foereningar.
FI841292A0 (fi) Nya timololmellanprodukter.
FI851774L (fi) Foerfarande foer framstaellning av nya kinolinderivat.
FI862679A0 (fi) Nya foereningar.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MM Patent lapsed

Owner name: NOVARTIS AG